MedPath

Research to study efficacy of steroids in women who are delivered between 34 and 36plus6 weeks of gestation.

Phase 3
Completed
Conditions
Health Condition 1: O601- Preterm labor with preterm delivery
Registration Number
CTRI/2019/09/021321
Lead Sponsor
Fluid Research CMCH
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
825
Inclusion Criteria

All women requiring delivery between 34 and 36plus6 weeks for :

-Preeclampsia

-IUGR or Oligohydraminos

-GDM

-PPROM

-Preterm labour with possible delivery within 1 week (more than 3cms dilated or 75 percent effacement)

-Any other reason for preterm delivery

Exclusion Criteria

-Definite evidence of infection

-Abruptio placenta

-Pregestational diabetes

-TWINS

-Received previous course of steroids

-Expected delivery within 12 hours (dilatation more than 8 cms with Regular contractions)

-Lack of early dating scan

-Major congenital anomalies and lung anomalies detected antenatally

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Respiratory distress in the newborn baby defined as tachypnea, grunting, chest indrawing, nasal flare, cyanosis or need for oxygen persisting beyond 2 hours of lifeTimepoint: 2 hours after birth
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath